Exploring the Scientific Foundations & Clinical Impact of PureGel™ HOCl Nano-Hydrogel

Event date: April 9, 2025

 

You’re watching a previously recorded webinar exploring the scientific foundation and clinical relevance of PureGel™—Biomiq’s HOCl-based nano-hydrogel developed for advanced wound care.

In this 45-minute session, our expert speakers unpack the role of HOCl in disrupting biofilm, reducing odour, and supporting optimal healing environments in chronic wounds. You’ll also see how PureGel™ is used in clinical practice through real-world patient cases.

 

View in full screen >

Speakers:

Dr. Lori Robins – Professor of Chemistry, University of Washington Bothell

Dr. Kevin Woo – Wound Care Clinician, UHN Toronto & Professor, Queen’s University

Robert Fuller – Co-Founder & Managing Director, Biomiq Inc.

 

Interested in evaluating PureGel™ or discussing how it might fit into your wound care protocols? Contact our team to learn more or request a sample.

Related products

PureGel™

A pure, stable hypochlorous acid (HOCl) formulation in the form of an isotonic hydrogel for skin, wounds and burns. Provides extended delivery over time and disrupts biofilm.

View product

LEADING THE WAY IN HOCl FOR HEALTHCARE

At Biomiq, we are passionate about our formulations and energized by our commitment to make a difference in people’s lives and in the world.

Get in Touch